CTSO

Cytosorbents Corporation | Healthcare

-0.89029%

Analisi Pre-Earnings (Antonio AI)

2025-12-18
Sentiment
60.0/100
Salute

Caution

Verdict

The narrative has some positive undertones with talk of 'progress' and 'new data', but the black box on the financials is a non-starter. ⚠️ I don't make bets without seeing the balance sheet; this could be a cash-burning machine headed for dilution. 📉

Catalysts
  • Positive regulatory update on the DrugSorb-ATR pathway
  • Better-than-expected data from blood-purification programs
Rischi
  • Unknown and potentially disastrous financial health (high cash burn, low runway, high debt)
Approfondisci con Antonio
Valutazione
P/E (TTM)-3.9720104440492237
Forward P/E-3.9720104440492237
P/S1.2248401399640978
Market Cap45442080
Finanze & Debito
CashNone
DebtNone
Debt/Equity3.0084257206208425
Current Ratio2.107693829113924
Redditività
ROE-0.9153772117264632
Profit Margin-0.3081417286407948
Operating Margin-0.41945470918081085
Rev. Growth0.14507234416600212
Ultime News (Context per AI)